logo
China Expanding Haifa Port, Endangering Israeli and American Security

China Expanding Haifa Port, Endangering Israeli and American Security

Newsweek19-05-2025

Advocates for ideas and draws conclusions based on the interpretation of facts and data.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
"Israel must halt this expansion, reassess the Haifa arrangement, and align itself once again with the values and interests it claims to share with the United States," Gadeer Kamal-Mreeh, a former member of the Knesset, Israel's parliament, wrote in a recent op-ed. "Anything less is a betrayal of our shared security—and of the American trust we rely on."
In March, the government of Prime Minister Benjamin Netanyahu issued permission to China's state-owned Shanghai International Port Group (SIPG) to double the capacity of its Bay Port in Haifa. The controversial decision entrenches China in one of Israel's most strategic locations and reflects the continuing ambivalence of countries toward the Chinese Communist Party.
Israeli security professionals in 2015 were alarmed when Israel Ports Co., without adequate interagency review, selected SIPG to run the Haifa port for 25 years.
An Israeli Navy fast patrol boat cruises in the port of Haifa in northern Israel on October 30, 2024.
An Israeli Navy fast patrol boat cruises in the port of Haifa in northern Israel on October 30, 2024.
AHMAD GHARABLI/AFP via Getty Images
The threat was obvious. Haifa Bay Port is close to Haifa's airport and is a mere 1.8 kilometers away from the Israeli navy's main base. Haifa, in the northern part of the country, has the Jewish state's largest port.
"Israel's seaports are critical strategic infrastructure," Shaul Chorev, a retired Israeli Navy rear admiral and now a director at the Haifa-based Institute for Maritime Policy and Strategy, told Newsweek. The Haifa Bay Port, he pointed out, "is considered to be amongst the country's most important strategic assets."
"To operate the facility, Shanghai International Port Group will have to connect to all the internet systems of both the harbor and the Ministry of Transportation, exposing them to manipulation, data mining and cyber warfare in the service of Chinese government interests," states the September 2019 report by the University of Haifa-Hudson Institute Consortium on the Eastern Mediterranean, co-chaired by Rear Admiral Chorev. "Given the military and intelligence ties among China, Russia and Iran, the Haifa port arrangements create the risk that China might, under some circumstances, obtain sensitive Israeli naval, merchant shipping and maritime infrastructure information and provide it to Iran."
Iran, therefore, will now have an expanded listening post in Haifa. SIPG can monitor what comes in and out of that port, especially general cargo. At a time of war, the Chinese company could disable cranes at the port or even engage in acts of sabotage, damaging or disabling ships.
Why would the Netanyahu government allow the Haifa port expansion? For too long there has been a failure, around the world but especially in the U.S., to acknowledge the danger posed by China's regime. Even today, in the face of clear evidence that the regime leverages investment and commercial relations to accomplish malicious ends, countries continue to accept Chinese money.
The one obvious solution for Israel is to cancel SIPG's concession. A cancellation, Kamal-Mreeh told Newsweek, "would likely be a highly complex and sensitive move" and "would require a strong political consensus in Israel."
Once such a consensus is reached, there are few legal impediments to a cancellation. Section 9(b) of the May 2015 contract awarding the port concession to SIPG provides that Israel's transport minister, with the consent of the finance minister and after consultation with SIPG, may "cancel or restrict the authorization if he deems it necessary to address the needs of the economy or for reasons of public interest."
China's backing for attacks on Israel would seem to qualify as a "reason of public interest." The Chinese state, for instance, has provided and continues to provide economic, diplomatic, propaganda, and weapons support for Iran's October 7 attack on Israel, and since then Beijing has gone all-in on the Palestinian cause. All three main Iranian proxies—Hamas, Hezbollah and the Houthi militia—have large quantities of Chinese weapons. China supplies critical components, such as computer chips, for Iran's own weaponry.
Of even greater concern, China has provided most of what Iran needs for its nuclear weapons program. For a long time, the international community looked the other way as China, both directly and through the nuclear black market ring of Dr. A.Q. Khan of Pakistan, helped Iran's "atomic ayatollahs" enrich uranium for the world's most destructive devices and take other steps needed for a bomb.
Is cancellation of the port concession possible?
"The feasibility depends largely on the evolving regional security context and the level of support from key allies, particularly the United States," said Kamal-Mreeh, now CEO of Washington, D.C.-based GKM Global Consulting. "Growing concerns over national security and critical infrastructure resilience—especially in light of shifting global alliances—could push the issue higher on Israel's strategic agenda."
China will certainly be upset if SIPG is ejected. Beijing is now throwing a tantrum because CK Hutchison, a public Hong Kong company, had tentatively agreed to sell to BlackRock 199 berths in 43 ports in 23 countries. Two of the ports are in the Panama Canal Zone.
Beijing's intervention in the BlackRock deal shows that it considers ports to be strategic assets, which should encourage the rest of the world to consider these facilities in the same light.
Panama's comptroller general and attorney general are now seeking to cancel CK Hutchison's concessions to its two Canal Zone ports. Israel should be doing the same with SIPG's port in Haifa.
Gordon G. Chang is the author of Plan Red: China's Project to Destroy America and The Coming Collapse of China. Follow him on X @GordonGChang.
The views expressed in this article are the writer's own.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Today in History: June 8, Trump indicted on classified document charges
Today in History: June 8, Trump indicted on classified document charges

Boston Globe

time27 minutes ago

  • Boston Globe

Today in History: June 8, Trump indicted on classified document charges

In 1789, in an address to the US House of Representatives, James Madison proposed amending the Constitution to include a Bill of Rights. In 1949, George Orwell's novel '1984' was first published. In 1966, a merger was announced between the National and American Football Leagues, to take effect in 1970. In 1967, during the Six-Day War, 34 American crew members were killed when Israel attacked the USS Liberty, a Navy intelligence-gathering ship in the Mediterranean Sea. (Israel later said the Liberty had been mistaken for an Egyptian vessel.) In 1968, US authorities announced the capture in London of James Earl Ray, the suspected assassin of civil rights leader the Rev. Dr. Martin Luther King Jr. In 1978, a jury in Clark County, Nev., ruled the so-called 'Mormon Will,' purportedly written by the late billionaire Howard Hughes, was a forgery. Advertisement In 1995, US Marines rescued Captain Scott O'Grady, whose F-16C fighter jet had been shot down by Bosnian Serbs on June 2. In 2009, North Korea's highest court sentenced American journalists Laura Ling and Euna Lee to 12 years' hard labor for trespassing and 'hostile acts.' (The women were pardoned in early August 2009 after a trip to Pyongyang by former President Bill Clinton.) In 2017, former FBI Director James Comey, testifying before Congress, asserted that President Trump fired him to interfere with Comey's investigation of Russia's ties to the Trump campaign. In 2021, Ratko Mladić, the military chief known as the 'Butcher of Bosnia' for orchestrating genocide, crimes against humanity, and war crimes in the Balkan nation's 1992-95 war, lost his final legal battle when UN judges rejected his appeal and affirmed his life sentence. In 2023, PresidentTrump was indicted by a grand jury in Miami on 37 felony counts related to the alleged mishandling of classified documents that had been moved to Mar-a-Lago, Trump's Florida home. (The case against Trump was abandoned following Trump's November 2024 presidential election victory.)

New disputes emerge ahead of US-China trade talks in London
New disputes emerge ahead of US-China trade talks in London

Hamilton Spectator

time38 minutes ago

  • Hamilton Spectator

New disputes emerge ahead of US-China trade talks in London

BEIJING (AP) — U.S.-China trade talks in London this week are expected to take up a series of fresh disputes that have buffeted relations, threatening a fragile truce over tariffs. Both sides agreed in Geneva last month to a 90-day suspension of most of the 100%-plus tariffs they had imposed on each other in an escalating trade war that had sparked fears of recession . Since then, the U.S. and China have exchanged angry words over advanced semiconductors that power artificial intelligence, 'rare earths' that are vital to carmakers and other industries, and visas for Chinese students at American universities. President Donald Trump spoke at length with Chinese leader Xi Jinping by phone last Thursday in an attempt to put relations back on track. Trump announced on social media the next day that trade talks would be held on Monday in London. Technology is a major sticking point The latest frictions began just a day after the May 12 announcement of the Geneva agreement to 'pause' tariffs for 90 days. The U.S. Commerce Department issued guidance saying the use of Ascend AI chips from Huawei , a leading Chinese tech company, could violate U.S. export controls. That's because the chips were likely developed with American technology despite restrictions on its export to China, the guidance said. The Chinese government wasn't pleased . One of its biggest beefs in recent years has been over U.S. moves to limit the access of Chinese companies to technology, and in particular to equipment and processes needed to produce the most advanced semiconductors. 'The Chinese side urges the U.S. side to immediately correct its erroneous practices,' a Commerce Ministry spokesperson said. U.S. Commerce Secretary Howard Lutnick wasn't in Geneva but will join the talks in London. Analysts say that suggests at least a willingness on the U.S. side to hear out China's concerns on export controls . China shows signs of easing up on rare earths One area where China holds the upper hand is in the mining and processing of rare earths . They are crucial for not only autos but also a range of other products from robots to military equipment. The Chinese government started requiring producers to obtain a license to export seven rare earth elements in April. Resulting shortages sent automakers worldwide into a tizzy. As stockpiles ran down, some worried they would have to halt production. Trump, without mentioning rare earths specifically, took to social media to attack China. 'The bad news is that China, perhaps not surprisingly to some, HAS TOTALLY VIOLATED ITS AGREEMENT WITH US,' Trump posted on May 30. The Chinese government indicated Saturday that it is addressing the concerns, which have come from European companies as well. A Commerce Ministry statement said it had granted some approvals and 'will continue to strengthen the approval of applications that comply with regulations.' The scramble to resolve the rare earth issue shows that China has a strong card to play if it wants to strike back against tariffs or other measures. Plan to revoke student visas adds to tensions Student visas don't normally figure in trade talks, but a U.S. announcement that it would begin revoking the visas of some Chinese students has emerged as another thorn in the relationship. China's Commerce Ministry raised the issue when asked last week about the accusation that it had violated the consensus reached in Geneva. It replied that the U.S. had undermined the agreement by issuing export control guidelines for AI chips, stopping the sale of chip design software to China and saying it would revoke Chinese student visas. 'The United States has unilaterally provoked new economic and trade frictions,' the ministry said in a statement posted on its website. U.S. Secretary of State Marco Rubio said in a May 28 statement that the United States would 'aggressively revoke visas for Chinese students, including those with connections to the Chinese Communist Party or studying in critical fields.' More than 270,000 Chinese students studied in the U.S. in the 2023-24 academic year. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .

Will Trump's policies kill Massachusetts' life sciences leadership?
Will Trump's policies kill Massachusetts' life sciences leadership?

Boston Globe

timean hour ago

  • Boston Globe

Will Trump's policies kill Massachusetts' life sciences leadership?

Advertisement Although the industry is centered in eastern Massachusetts, there's a statewide benefit from all the tax dollars those businesses and workers pay. Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up In all, Massachusetts organizations — including universities, research institutes, and hospitals — received $3.5 billion in funding from the National Institutes of Health. Massachusetts-headquartered companies raised $3.26 billion in venture capital funding. Among all drugs in the development pipeline in the United States, 15 percent were being made by companies headquartered in Massachusetts. But actions taken by President Trump and his administration — cutting funding for scientific research and universities, flirting with tariffs, fanning skepticism about vaccines — threaten to devastate the ecosystem. Today, the industry is at a precipice, and uncertainty abounds. Some companies are already feeling the pinch of terminated federal grants, while others are anxious about what might come. Taken together, Trump's policies could force some companies and scientists to take their money, talents, and products overseas. Advertisement Christopher Locher, CEO of Lowell-based Versatope Therapeutics, which develops a platform to deliver vaccines and therapeutics, said he worries the Greater Boston life sciences ecosystem is 'being flushed down the toilet.' For example, Trump is Trump's funding cuts are already having a large impact on some local companies. Part of the problem is the Trump administration isn't only cutting funding, but it's picking which technologies to fund — in some cases apparently based on politics more than science. Take flu vaccines. The Trump administration recently announced a $500 million campaign to fund the development of a universal flu vaccine, which doesn't require annual updates, using technology being worked on But simultaneously, he cut funding for other work on a universal flu vaccine. Versatope Therapeutics got $14 million in NIH funding and spent five years developing a universal flu vaccine. It had approval from the US Food and Drug Administration to begin clinical trials when Trump terminated the contract's remaining $8 million, with the reason given being 'convenience,' Locher said. Trump also Advertisement Company executives say decisions by Trump officials to disinvest in vaccine-related technology — and concerns about whether government will approve new technology — means it's nearly impossible to find private investment funding to replace lost federal dollars. 'We're faced with bankruptcy in the very near future,' Locher said. Ironically, given Trump's stated commitment to bringing businesses back to the United States, one potential option Locher is eyeing is opening a subsidiary abroad. Conducting clinical trials would be cheaper in another country, whether in Europe, Australia, or China, Locher said, and some countries are offering financial incentives to American companies to relocate. Companies also face a potential workforce brain drain. There have been MassBio officials said China has less rigorous — but faster — safety and research protocols than the US. Australia allows a faster timeline for clinical trials. If regulatory approval of medicines is held up because the FDA is understaffed, companies may seek European regulatory approval instead. The loss of talent to foreign countries will be compounded if the pipeline of local university graduates dries up. One draw for life sciences companies to Boston/Cambridge is the presence of elite schools like Harvard and MIT, with their potential for faculty collaboration and skilled graduates. Advertisement Trump is trying to Chip Clark, CEO at Vibrant Biomedicines in Cambridge, said cuts to university research funding both 'shrink the pipeline of great ideas' that form the basis for many biotech startups and translate to fewer available scientists. Clark said the administration's policies 'seem like a deliberate attempt to try to cede scientific leadership to Europe and Japan and Korea and China. ... They will be delighted to capitalize on our talent, technology, and investment capital to make their robust biotech sectors grow and ultimately compete successfully against the US industry,' he said. Don Ingber, founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, said he has postdocs with US visas applying for jobs in Europe, and others who were accepted to work at Harvard but are going elsewhere. 'The fact that places like Harvard and MIT and American universities are magnets for the best and brightest from around the world is what's driven our technology economy and certainly the Boston/Cambridge ecosystem,' Ingber said. 'With this uncertainty, I fear we'll lose a generation.' Ingber, who was forced to stop work on two government-funded projects on drugs designed to prevent injury from radiation exposure, compared administration policies to 'eating seed corn' needed to grow crops. Advertisement Trump's vendetta will undermine one of the most vibrant state economies in the country and set back American science by years. And it's not just eastern Massachusetts that will pay a price; the entire country will. As Ingber noted, it might take years to see the impact of medicines or technologies that aren't developed because of these shortsighted cuts. Editorials represent the views of the Boston Globe Editorial Board. Follow us

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store